|
Regulatory Affairs Journal (RAJ) Pharma is the leading source of global news, comment and analysis of regulation in the pharmaceutical and biotech industries.
Delivering unrivalled coverage of pharmaceutical regulatory intelligence, RAJ Pharma uses a network of experienced, local reporters to provide you with a truly international and independent perspective, keeping readers ahead of the worldwide rules governing the development, launch and post-market surveillance of medicines and combination products.
From pharma and biotech companies to medicines agencies to legal firms, RAJ Pharma subscribers know the value of the independent pharmaceutical regulatory analysis that only RAJ Pharma provides.
Take a free 10 day trial subscription to receive daily email alerts covering all the latest global regulatory news, plus access the current issue online and search the archive of articles covering:
-
Regulatory agencies and legislation
-
Application requirements and guidelines
-
Research and development
-
Patents and intellectual property
-
International harmonisation
-
Paediatric legislation
-
Pharmacovigilance
-
Pharmacoeconomics
-
Drug safety
RAJ Pharma
Informa UK Ltd
Telephone House
69-77 Paul Street
London
EC2A 4LQ
Tel: +44 (0) 20 7017 5000
Fax: +44 (0) 20 7017 7850
Email: regulatory@informa.com
Editorial Board
The RAJ Pharma editorial board comprises a range of regulatory experts from industry and agencies alike. They can be contacted at regulatory@informa.com
|
|
|
|
|
|
Brian Ager – Director General, EFPIA, Brussels, Belgium
|
Peter Bogaert – Covington and Burling LLP, Brussels, Belgium
|
Manuel Campolini – Member of the Brussels Bar, Stibbe, Brussels, Belgium
|
Rick Clayton – IFAH-Europe, Brussels, Belgium
|
Ian Dodds-Smith – Arnold and Porter, London, UK
|
|
|
|
|
|
|
Brenton James – Consultant in Strategic Regulatory Affairs in the European Union, Ascot, UK
|
John Lisman – NautaDutilh NV, Amsterdam, the Netherlands
|
Dr Brian Matthews – Independent consultant, Croydon, UK
|
Maarten Meulenbelt – Howrey LLP, Brussels, Belgium
|
Dr J Mike Morris – Irish Medicines Board, Dublin, Ireland
|
|
|
|
|
|
|
Prof Tamás L Paál – Director-General, National Institute of Pharmacy, Budapest, Hungary
|
Prof Lembit Rägo – WHO Geneva, Switzerland
|
Isaac Setton – Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel
|
Dr Manuel Zahn – 3R Pharma Consulting, Keltern, Germany
|
|
Editorial Correspondents:
RAJ Pharma’s correspondents are based locally around the world. To contact a correspondent please email regulatory@informa.com
|
Argentina
|
Australia
|
Brazil
|
Egypt
|
Germany
|
|
|
|
|
|
|
Miguel Napolitano – CETUS SRL, Buenos Aires
|
Carmen Langley – Ferring Pharmaceuticals Pty Ltd, Sydney
|
Maria Regina Shimizu – Galderma Brasil Ltd, São Paulo
|
Gihan Taha – Medical Union Pharm Co, Cairo
|
Dr Jörg Schickert – Lovells, Munich
|
|
|
|
|
|
|
|
Germany
|
Hungary
|
India
|
Israel
|
Japan
|
|
|
|
|
|
|
|
Dr Stefan Schulz – Lovells, Munich
|
Tamás Paál – National Institute of Pharmacy, Budapest
|
Rashmi Kulshrestha – Regulatory Wisdom, New Delhi
|
Isaac Setton – Teva Pharmaceutical Industries Ltd, Petah Tikva
|
Masami Tamura – CoreMed Corporations, Osaka
|
|
|
|
|
|
|
|
Jordan
|
Norway
|
South Africa
|
South Korea
|
Spain
|
|
|
|
|
|
|
|
Sabih R Kukhun – Al-Sahl Drugstore, Amman
|
Hilde Kloster Smerud – Smerud Medical Research Norway AS, Oslo
|
Maureen Kirkman – Independent consultant, Vorna Valley
|
Kuk Whan Choi – SAMA Pharm Co Ltd, Seoul
|
Maria Luisa Bravo – Quimica Farmaceutica Bayer SA, Barcelona
|
|
|
|
|
|
|
|
Sweden
|
Switzerland
|
United Arab Emirates
|
|
|
|
|
|
|
|
|
Ingegerd Wennerbeck – Weteko Publisher AB, Lund
|
Alan Chalmers – Pharma International Innovations Centre, Allschwil
|
Lina Kukhun Imam – Abu Dhabi
|
|
|
Subscriptions
New Subscriptions:
Zak McNally – zak.mcnally@informa.com
+44 (0) 20 7017 3555
Subscription Renewals:
Jonathan Mooney – jonathan.mooney@informa.com
+44 (0) 20 7017 6797
Customer Services:
Healthcare.enquiries@informa.com
+44 (0) 20 7017 5540
Marketing
Marketing Manager:
Andy Williams – andy.williams@informa.com
Publisher
Phil Solomon – phil.solomon@informa.com
Website
Assistant Editor:
Francesco Radicati – francesco.radicati@informa.com
|
Meet the team
Editorial team
Editorial Board
Editorial Correspondents
Other
RAJ enables companies to:
|
|
Make faster, better strategic decisions
|
|
|
Accelerate regulatory application processes
|
|
|
Achieve faster time to market for drugs
|
|
|
Minimise regulatory compliance costs
|
|
|
Maximise market share in existing and new sectors
|
|
